Fitness5 months ago
FDA: Exblifep Approved for Complicated Urinary Tract Infections
The FDA approved cefepime/enmetazobactam (Exblifep) in February 2024 for the treatment of complicated urinary tract infections (cUTI) including pyelonephritis caused by designated susceptible microorganisms in patients...
